4833M 15/850 (Actoplus met 850 mg / 15 mg)
Generic Name: metformin/pioglitazone
This pill with imprint "4833M 15/850" is White, Elliptical / Oval and has been identified as Actoplus met 850 mg / 15 mg. It is manufactured by Takeda Pharmaceuticals America, Inc..
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 4833M 15/850
- 850 mg / 15 mg
- 18.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
hypromellose 2910 (6 mPa.s)
polyethylene glycol 8000
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|00093-5050||Teva Pharmaceuticals USA, Inc.|
|54868-5553||Physicians Total Care Inc (repackager)|
|35356-0130||Lake Erie Medical and Surgical Supply (repackager)|
More about ActoPlus Met (metformin / pioglitazone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews – Add your own review/rating
- Generic Availability
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.